As of Jun 27
| +0.02 / +2.15%|
The 3 analysts offering 12-month price forecasts for OncoGenex Pharmaceuticals Inc have a median target of 3.00, with a high estimate of 4.00 and a low estimate of 1.00. The median estimate represents a +215.79% increase from the last price of 0.95.
The current consensus among 3 polled investment analysts is to Buy stock in OncoGenex Pharmaceuticals Inc. This rating has held steady since June, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.